PMH37 COST CONSEQUENCE ASSOCIATED WITH DIFFERENT INITIAL MOOD STABILIZERS FOR NEWLY TREATED PATIENTS WITH BIPOLAR DISORDERS

Autor:	R Jang, JJ Guo, W Carson, PE Keck, Hong Li
Rok vydání:	2004
Předmět:	medicine.medical_specialty Mood business.industry Cost consequences Health Policy Public Health Environmental and Occupational Health medicine Psychiatry business
Zdroj:	Value in Health. 7:274-275
ISSN:	1098-3015
DOI:	10.1016/s1098-3015(10)62233-4
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f5780a1006022e749d771a6dc60eb66 https://doi.org/10.1016/s1098-3015(10)62233-4 Zobrazit plný text záznamu Full Text from ScienceDirect Plný text